Institut du Cancer de Montpellier
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Institut du Cancer de Montpellier
The intellectual property, also held by Eureka, may offer a new pathway for treating relapsed MM patients. Sorrento inks cancer partnerships with Karolinska Institutet and Mayo Clinic.
- Academic and Research Institutions
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.